Squarepoint’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,734
Closed -$49K 3549
2021
Q4
$49K Sell
2,734
-878
-24% -$26.3K ﹤0.01% 3025
2021
Q3
$134K Sell
3,612
-2,991
-45% -$133K ﹤0.01% 2610
2021
Q2
$393K Buy
+6,603
New +$400K ﹤0.01% 2325
2021
Q1
Sell
-9,650
Closed -$584K 3637
2020
Q4
$584K Buy
9,650
+6,307
+189% +$431K ﹤0.01% 1697
2020
Q3
$264K Sell
3,343
-11,023
-77% -$879K ﹤0.01% 1903
2020
Q2
$898K Buy
+14,366
New +$836K 0.01% 1002
2020
Q1
Sell
-4,412
Closed -$534K 2530
2019
Q4
$534K Buy
4,412
+2,463
+126% +$354K ﹤0.01% 1739
2019
Q3
$354K Buy
+1,949
New +$275K ﹤0.01% 1803
2018
Q4
Sell
-665
Closed -$218K 2235
2018
Q3
$218K Buy
665
+317
+91% +$97.1K ﹤0.01% 1728
2018
Q2
$109K Sell
348
-986
-74% -$301K ﹤0.01% 1636
2018
Q1
$325K Buy
+1,334
New +$374K 0.01% 1281
2017
Q4
Sell
-454
Closed -$120K 2350
2017
Q3
$120K Buy
+454
New +$131K ﹤0.01% 1492
2017
Q2
Sell
-367
Closed -$132K 1812
2017
Q1
$132K Sell
367
-247
-40% -$76.4K ﹤0.01% 1372
2016
Q4
$177K Buy
614
+352
+134% +$109K 0.01% 1480
2016
Q3
$89K Buy
+262
New +$95.7K 0.01% 958
2016
Q2
Sell
-312
Closed -$100K 1353
2016
Q1
$100K Sell
312
-130
-29% -$44.3K 0.01% 1070
2015
Q4
$229K Buy
+442
New +$163K 0.03% 921

Other funds holding TXMD

Squarepoint's TXMD Position: Q1 2022 in Review

Squarepoint sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 2,734 shares — an estimated $49K sold.

Squarepoint first reported a position in TXMD in Q4 2015 and held it in 17 quarters. The position peaked at $898K in Q2 2020. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.

  • Squarepoint reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
  • Squarepoint sold 2,734 TherapeuticsMD shares in Q1 2022, an estimated $49K.
  • Squarepoint first reported a position in TherapeuticsMD in Q4 2015 and held it in 17 quarters.
  • Squarepoint's TherapeuticsMD position peaked at $898K in Q2 2020.
  • 124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.

Based on Squarepoint's 13F filing for Q1 2022, filed 16 May 2022.